Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Heteroplasmy distribution in human retinal mitochondrial disease
Author Affiliations & Notes
  • Robert F Mullins
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa, United States
    Institute for Vision Research, University of Iowa, Iowa City, Iowa, United States
  • Footnotes
    Commercial Relationships   Robert Mullins None
  • Footnotes
    Support  NIH grants: R01EY033308, T32GM008629, T32GM139776, F30EY034009, P30EY025580, F30EY031923
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6470. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Robert F Mullins; Heteroplasmy distribution in human retinal mitochondrial disease. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6470.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Presentation Description : Diseases caused by the m3243A.G mutation in the mitochondrial genome have a variable phenotypic spectrum of severity that can include geographic atrophy of the retinal pigment epithelium (RPE). In a phenomenon referred to as heteroplasmy, mitochondrial genomes harboring mutations may not be homogeneously distributed through all tissues and all cells, but until recently determining the mutation load in different cell types was very difficult. In this presentation we will discuss what we are learning from studying donated eyes from patients with m.3243A>G mutation and the anatomical and molecular changes in the eye at the single cell level.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×